Schizophrenia Research
Volume 44, Issue 3 , Pages 245-246 , 1 September 2000

Immune–biochemical interactions in schizophrenia

  • K Taylor

      Affiliations

    • Corresponding Author InformationTel.: +44-1865-272540; fax: +44-1865-272469

Received 7 July 1999 ,Accepted 24 September 1999.

References 

  1. Bonventre JV, Huang Z, Taheri MRO, Leary E, Li E, Moskowitz MA, et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 1997;390:622–625
  2. Franzek E, Beckmann H. Schizophrenia and birth seasonality — contrary results in relation to genetic risk. Fortschr. Neurol. Psychiatr. 1993;61:22–26
  3. Gattaz WF, Hubner CV, Nevalainen TJ, Thuren T, Kinnunen PK. Increased serum phospholipase A2 activity in schizophrenia: a replication study. Biol. Psychiatry. 1990;28:495–501
  4. Gordon N. Nutrition and cognitive function. Brain Dev. 1997;19:165–170
  5. Huang RT, Lichtenberg B, Rick O. Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection. FEBS Lett. 1996;392:59–62
  6. Kaburaki J, Kuwana M, Yamamoto M, Kawai S, Ikeda Y. Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am. J. Hematol. 1997;54:209–213
  7. Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, et al. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J. Neurochem. 1998;71:2634–2637
  8. Kurtz G, Mueller N. The antiphospholipid syndrome and psychosis. Am. J. Psychiatry. 1994;151:1841–1842
  9. Mira JP, Dubois T, Oudinet JP, Lukowski S, Russo Marie F, Geny B. Inhibition of cytosolic phospholipase A2 by annexin V in differentiated permeabilized HL-60 cells. Evidence of crucial importance of domain I type II Ca2+-binding site in the mechanism of inhibition. J. Biol. Chem. 1997;272:10474–10482
  10. Nishizaki T, Nomura T, Matsuoka T, Tsujishita Y. Arachidonic acid as a messenger for the expression of long-term potentiation. Biochem. Biophys. Res. Commun. 1999;254:446–449
  11. Rand JH, Wu XX, Guller S, Scher J, Andree HA, Lockwood CJ. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am. J. Obstet. Gynecol. 1997;177:918–923
  12. Smythies JR. Oxidative reactions and schizophrenia: a review-discussion. Schizophr. Res. 1997;24:357–364
  13. Speijer H, Jans SW, Reutelingsperger CP, Hack CE, van der Vusse GJ, Hermens WT. Partial coverage of phospholipid model membranes with annexin V may completely inhibit their degradation by phospholipase A2. FEBS Lett. 1997;402:193–197
  14. Torrey EF, Bowler AE, Rawlings R, Terrazas A. Seasonality of schizophrenia and stillbirths. Schizophr. Bull. 1993;19:557–562
  15. Wright P, Takei N, Rifkin L, Murray RM. Maternal influenza, obstetric complications, and schizophrenia. Am. J. Psychiatry. 1995;152:1714–1720

PII: S0920-9964(99)00194-2

Schizophrenia Research
Volume 44, Issue 3 , Pages 245-246 , 1 September 2000

Article Tools